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Abstract
Primary familial brain calcification (PFBC) is an age-dependent and rare neurode-
generative disorder characterized by microvascular calcium phosphate deposits in the 
deep brain regions. Known genetic causes of PFBC include loss-of-function mutations 
in genes involved in either of three processes—platelet-derived growth factor (PDGF) 
signaling, phosphate homeostasis or protein glycosylation—with unclear molecular 
links. To provide insight into the pathogenesis of PFBC, we analyzed murine models 
of PFBC for the first two of these processes in Pdgfbret/ret and Slc20a2−/− mice with 
regard to the structure, molecular composition, development and distribution of 
perivascular calcified nodules. Analyses by transmission electron microscopy and im-
munofluorescence revealed that calcified nodules in both of these models have a 
multilayered ultrastructure and occur in direct contact with reactive astrocytes and 
microglia. However, whereas nodules in Pdgfbret/ret mice were large, solitary and smooth 
surfaced, the nodules in Slc20a2−/− mice were multi-lobulated and occurred in clusters. 
The regional distribution of nodules also differed between the two models. Proteomic 
analysis and immunofluorescence stainings revealed a common molecular composition 
of the nodules in the two models, involving proteins implicated in bone homeostasis, 
but also proteins not previously linked to tissue mineralization. While the brain 
vasculature of Pdgfbret/ret mice has been reported to display reduced pericyte coverage 
and abnormal permeability, we found that Slc20a2−/− mice have a normal pericyte 
coverage and no overtly increased permeability.  Thus, lack of pericytes and increase 
in permeability of the blood–brain barrier are likely not the causal triggers for PFBC 
pathogenesis. Instead, gene expression and spatial correlations suggest that astrocytes 
are intimately linked to the calcification process in PFBC.
INTRODUCTION
Primary familial brain calcification (PFBC), also known as 
Fahr’s disease, is a rare, age-dependent neurological condition 
characterized by bilateral symmetrical calcifications along 
capillaries in specific regions of the brain parenchyma 
(7, 10, 18, 19, 27, 43). While approximately one-third of 
the affected individuals stay asymptomatic, a wide variety 
of neuropsychiatric and motor dysfunctions have been reported 
for the symptomatic individuals, including Parkinsonism, 
dementia, psychosis and cognitive inabilities. Sporadic as well 
as inherited autosomal dominant and autosomal recessive 
cases of PFBC have been reported (26, 27, 43, 45), the 
underlying mechanisms of which have not been fully eluci-
dated. Over the past years, causative mutations in five genes 
have been discovered: solute carrier family 20 (phosphate 
transporter) member 2 (SLC20A2) (42), xenotropic and poly-
tropic retrovirus receptor 1 (XPR1) (20), platelet-derived 
growth factor-B (PDGFB) (17), platelet-derived growth factor 
receptor-β (PDGFRB) (29) and myogenesis-regulating glycosi-
dase (MYORG) (45). SLC20A2 and XPR1 encode phosphate 
transporters, providing a link between phosphate imbalance 
and PFBC. On the other hand, while several different loss-
of-function mutations have been described in PDGFB and 
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its cognate receptor-coding gene PDGFRB in PFBC families, 
it is currently unknown how loss of PDGF-B/PDGFRβ 
signaling triggers onset of brain calcification. It is also unclear 
how loss of the glycosidase MYORG, which is specifically 
expressed in astrocytes in the brain, cause PFBC.
To date, mouse mutants of Slc20a2, Pdgfb and Myorg 
(also annotated as AI464131) have been reported to mimic 
PFBC. Homozygous knockouts for the Slc20a2 gene 
(Slc20a2−/−) develop cerebral calcifications from as early as 
1 month of age. Interestingly, vascular-associated calcifica-
tions have been reported also in other organs of Slc20a2−/− 
mice (14, 41). A second mouse model for PFBC carries a 
homozygous deletion of the retention motif  of PDGF-B 
(Pdgfbret/ret) (22, 30), preventing accumulation of the growth 
factor PDGF-B in the perivascular matrix, while still allow-
ing receptor binding and biological activity. Pdgfbret/ret mice 
have severely reduced numbers of pericytes in the brain 
and display a dysfunctional blood–brain barrier (BBB) (4). 
From 2  months of age, they display brain perivascular min-
eralized nodules with a histological appearance and ana-
tomical location closely resembling the human PFBC 
pathology (17). Myorg−/− mice display calcified nodules in 
the thalamic region of the brain at 9  months of age, seem-
ingly at lower abundance than what has been reported in 
Slc20a2−/− and Pdgfbret/ret mice (14, 17, 45).
In the present study, we analyzed and compared the ultra-
structure of calcifications in Pdgfbret/ret and Slc20a2−/− mice. 
This revealed both similarities and differences in the morphol-
ogy and location of the calcified nodules. We also found that 
the nodules in both models were in direct contact with at 
least two cell types: astrocytes and microglia. Using microdis-
sected and laser-captured material for mass spectrometry analy-
sis, we analyzed the protein content of the matrix that builds 
up the nodules in Pdgfbret/ret mice and used this knowledge 
to provide new insights into their possible origin and growth.
RESULTS
Transmission electron microscopy reveals a 
layered structure and cellular associations of 
perivascular calcifications in Pdgfbret/ret mice
We have previously described the occurrence of  calcified 
nodules in the Pdgfbret/ret mouse model and their pheno-
typic resemblance to the brain calcifications observed in 
human PFBC (17). In order to gain further insight into 
the structure of  calcifications, we investigated calcification-
prone deep brain regions of  adult Pdgfbret/ret mice by 
transmission electron microscopy (TEM). This analysis 
revealed that calcified nodules display a conspicuously 
layered structure, suggesting a discrete, possibly singular, 
point of  origin (nidus) from which they grow through 
the addition of  external layers, similar to the annual rings 
of  a tree stem (Figure 1A–G). At high magnification, the 
variable electron densities of  the different layers were 
clearly apparent (Figure 1A–C). We observed speckles 
of  highly electron dense material within the nodules, con-
sistent with the presence of  calcium phosphate deposits 
(Figure 1C, red arrowheads). We further observed a vari-
ation in the surfaces of  the calcified nodules, with some 
being rugged (Figure 1D, black arrowheads) and others 
smooth (Figure 1e–g, black arrows). These differences cor-
related with the outline of  the deeper layers, suggesting 
that a net deposition of  matrix take place at both surfaces, 
possibly faster at sites where layers are broader (compare 
Figure 1D and 1E, white arrowheads). Often, these dif-
ferences were seen at different areas of  the same nodule. 
In keeping with the microvascular association of  the nod-
ules, we often found blood vessels profiles in the close 
vicinity of  the nodules (Figure 1B). Moreover, we observed 
that two different cell types were often found in direct 
physical contact with the nodules. Astrocytes, recognizable 
through the presence of  a light (electron permissive) cyto-
plasm containing electron-dense granules (interpreted as 
glycogen deposits) (Figure 1E, red arrowhead) and dense 
bundles of  intermediate filaments (Figure 1E, red arrow), 
were apposed to the nodules and directly touching their 
calcified matrix at both rugged and smooth edges. We 
also found microglial/macrophage-type cells (henceforth 
referred to as microglia for brevity) directly contacting 
the calcified matrix. These cells were characterized by their 
electron-dense cytoplasm and an abundance of  mitochon-
dria (Figure 1F). In order to corroborate these observa-
tions, the alternative apposition of  astrocytes and microglia 
to the nodules was also supported by immunofluorescence 
(Figure 5, Supplementary Movies S1 and S2).
Taken together, these observations suggest that the calci-
fied nodules grow by the addition of external matrix layers, 
are in direct contact with at least two cell types—astrocytes 
and microglia.
Calcifications in Pdgfbret/ret mice are composed 
of both pro- and anti-osteogenic proteins
To investigate the molecular composition of the calcified 
nodules, we explored their protein content using mass spec-
trometry (Figure 2). First, we isolated calcified lesions from 
Pdgfbret/ret brains by manual microdissection under a fluorescent 
stereomicroscope. By exciting the tissue at 488  nm, we could 
easily distinguish the nodules from the surrounding brain 
matter in the green spectrum. During this procedure, vascular 
association of the nodules was easily observed. A similar-
sized area of neighboring neuropil was used as a control. 
From this material, proteins were extracted, and after diges-
tion, liquid chromatography and tandem mass spectrometry 
(LC-MS/MS) were performed in order to identify the protein 
content (Supplementary Table S1). From the calcified nodules, 
we could identify 456 proteins, whereas the control neuropil 
yielded 545 proteins. Of all detected proteins, 97 were found 
in the calcifications only (Supplementary Table S2).
Next, we performed a more accurate method of sample 
isolation, namely laser capture microdissection (LCM). We 
isolated nodules from Pdgfbret/ret mouse brain cryosections and 
used again a similar-sized area of surrounding neuropil as 
control. Extraction of proteins from such small amounts of 
calcified material proved to be challenging with existing pro-
tocols, and a new method for demineralization was developed 
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(see material and methods). After demineralization, we detected 
112 proteins, of which 66 were found only in the nodules 
(Supplementary Table S3). Comparing the two different meth-
ods revealed that 93 proteins were detected using both micro-
dissection and LCM. Finally, of these 93 proteins, 10 were 
detected exclusively in the calcified nodules (Table 1). Three 
of the 10 proteins have previously been associated with regu-
lation of bone mineralization: fetuin A (alpha 2-Heremans 
schmid glycoprotein, AHSG), matrix gla protein (MGP) and 
osteopontin (OPN). Intriguingly, OPN, AHSG and MGP have 
all been shown to inhibit bone formation (6, 13, 24). Three 
other proteins play roles in nervous system and neuronal 
development, as well as in neuronal synapse activity, namely 
amyloid precursor protein (APP), amyloid precursor-like pro-
tein 2 (APLP2) and the neurosecretory protein VGF (VGF) 
(2, 44). Secretogranin-1 (CHGB) and chromogranin A 
(CHGA), believed to have hormonal activity, are found as 
the major components of secretory granules in endocrine and 
neuroendocrine cells (11). Sparc-like 1 (SPARCL1) is a con-
stituent of the extracellular matrix, a secreted calcium-binding 
Figure 1. TEM analysis of Pdgfbret/ret mouse deep brain regions reveals 
nodules with layered structure and cellular association. A. Representative 
image of a calcification with two nodules with both a “rugged” and 
smooth surface area found in the deep brain region of a 5-month-old 
mouse. B. Magnified view of a multilayered calcification with varying 
electron density in close vicinity to a blood vessel. Red arrowheads in 
(C) show the presence of calcium phosphate crystals in the nodule. D. 
An illustration of a nodule with a “rugged” surface area (black 
arrowheads) in close proximity to an astrocyte. The surface structure 
(black arrowheads) correlates with the deeper layering (white 
arrowheads in D and E). E. Representative image of the immediate 
association of a smooth-surfaced (black arrows) calcified nodule with an 
astrocyte. Red arrowhead indicate electron dense glycogen granules 
and red arrow indicates cytoplasmic intermediate filaments. (F, G) 
Microglia in direct contact with a nodule with smooth surface area (black 
arrows).
Nahar et alPFBC Pathology in Two Mouse Models
Brain Pathology 0 (2019) 1–19
© 2019 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology
4
phosphoprotein and the evolutionary ancestor of proteins 
involved in tissue mineralization in tetrapods (16). Like 
SPARCL1, MGP also possesses calcium-binding activity (11, 
35). Lastly, cathepsin Z (CTSZ) belongs to the family of 
cysteine cathepsins and is a lysosomal proteinase (36).
Calcifications in Pdgfbret/ret and Slc20a2−/− have 
similar protein content but distinct morphology
After elucidation of the protein composition of the calcified 
nodules, we verified the protein composition of nodules in 
Figure 2. Flow chart for proteomics analysis. Schematic overview of 
the isolation of lesions from fresh brain tissue of Pdgfbret/ret mice using 
fluorescent stereomicroscope microdissection (left side) (n = 1), and 
from paraffin embedded tissue with laser capture microdissection 
(LCM), right side (n = 3). The number of detected proteins in neuropil 
and calcifications is depicted in the upper Venn diagrams (red and yellow 
respectively). The lower Venn diagram illustrates the high overlap of 
proteins that were detected in calcifications using both techniques. Of 
these 93 proteins, 10 were found to be exclusively present in 
calcifications.
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adult brain tissue sections from Pdgfbret/ret mice using immu-
nofluorescence (IF) and confocal imaging. While antibodies 
against APP, APLP2, SPARCL1, OPN, VGF and CHGA 
specifically labeled calcifications, MGP and CTSZ could not 
be detected in the calcifications using our tested antibodies 
(Figure 3A,B). The reason for this is unclear but may have 
to do with the availability of antigenic determinants in the 
nodular matrix. We could not verify the presence of CHGB 
or AHSG using our tested antibodies, neither in the calcifica-
tions, nor in any specific cell type in the adult mouse brain.
Because visualization of the nodules was made possible 
by IF staining of some of their constituent proteins, we 
compared the morphology, composition, cellular association 
and growth of the calcifications between Pdgfbret/ret and 
Slc20a2−/− mice. In both models, the nodules increased in 
both number and size over time (Figure 3A,C,D and 4A). 
By IF, we also concluded that they share a similar protein 
composition, i.e. they stained positively and with similar 
intensity using the same antibodies (Figure 3A). Moreover, 
by TEM analysis, nodules in Slc20a2−/− mice were found 
to display a multi-layered structure similar to that observed 
in Pdgfbret/ret nodules (Figure 4C). However, whereas Pdgfbret/
ret mice showed solitary large calcifications concentrated to 
the dorsal pons, thalamus, hypothalamus and midbrain, the 
nodules in Slc20a2−/− mice were generally smaller, more evenly 
spread throughout the deeper brain regions and were also 
occasionally found in the cortex, cerebellum and hippocampus 
(Figure 4A,B). In addition, the nodules in Slc20a2−/− mice 
displayed a multi-lobulated mulberry-like morphology, as 
opposed to the round pearl-like shapes of Pdgfbret/ret nodules 
(Figure 3A and 4A,C–D). While the occurrence of brain 
calcifications has previously been reported in heterozygous 
Slc20a2 knockouts (Slc20a2+/−) (40), we were not able to 
detect nodules in Slc20a2+/− mice. The reason for this is 
unclear, but similarly we have failed to detect calcifications 
in mice heterozygous for Pdgfbret, or heterozygous for Pdgfb 
or Pdgfrb knockout alleles (39) (and data not shown).
Astrocytes and microglia/macrophages  
are apposed to the calcified nodules
As shown, TEM analysis indicates that the calcified nodules 
are in direct contact with cells displaying ultrastructural 
signs of astrocytes and microglial/macrophage cells (Figure 
1D–G and 4D). To confirm that the nodules were indeed 
in contact by these two cell types, we made IF stainings 
on tissue sections from Slc20a2−/− and Pdgfbret/ret mice using 
antibodies against astrocytes (glial fibrillary acidic protein 
(GFAP)) and microglia (allograft inflammatory factor 
1  (IBA1)). Note that IBA1 antibodies recognize both micro-
glia and macrophages. These analyses confirmed the tight 
apposition of calcifications with astrocytes and microglia 
and further showed that the same nodule displayed an 
alternating contact with the two cell types, such that part 
of its surface was contacting one or more microglial cells, 
and part of the surface contacted one or more astrocytes 
(Figure 5). All nodules analyzed in this way displayed con-
tact with both cell types, and together, the astrocyte and 
microglial contacts encompassed most or all of the nodular 
circumference (Figure 5A–E and Supplementary Videos S1 
and S2). IF analysis also showed that the nodules in both 
mouse models were tangentially apposed to blood vessels 
at 2 and 12 months of age (Figure 6A–C and Supplementary 
Video S2). Interestingly, we also noted that in Pdgfbret/ret 
mice, calcifications were often associated with pericyte-covered 
capillaries, despite the general reduction in vessel pericyte 
coverage in this mouse model (4) (Figure 6A).
Slc20a2−/− mice show normal pericyte coverage 
and blood–brain barrier disruption permeability
A hallmark of Pdgfbret/ret mice is their reduced pericyte 
coverage and prominent BBB permeability through wide-
spread endothelial transcytosis. We have previously suggested 
that these features may trigger brain calcification in this 
mouse model, as well as in human PFBC (4, 17). We there-
fore asked if  pericyte coverage and BBB function was 
abnormal also in Slc20a2−/− mice. We found that the 
Slc20a2−/− mice had a normal pericyte coverage at both 3 
and 12 months of age in the cortex as well as in deeper 
brain regions, i.e. sites affected by brain calcification in this 
model (Figure 7A–C). Also, the BBB of the Slc20a2−/− mice 
did not display a general increase in permeability, as assessed 
by circulation of 1 kDa Alexa Fluor 555 cadaverine, a dye 
that strongly extravasates from the blood into the entire 
brain in Pdgfbret/ret mice (Figure 7D).
Multiple cellular sources of nodular matrix 
proteins
In order to get an indication of the cellular origin(s) of 
the protein constituents of the calcifications and to explore 
the potential role they play in the inception of the disease, 
we explored two mouse brain single-cell sequencing databases. 
First, we investigated specific expression of the genes in 
the cells comprising or associated with the BBB (38). Next, 
Table 1. Overview of the detected proteins in calcified nodules. The 
selective presence of peptides uniquely identified in calcified nodules 
obtained by regular microdiessection and laser capture microdiessec-
tion (LCM).
Uniprot 
ID Ensembl ID Protein names
Gene 
names
P12023-2 ENSMUSG00000022892 Amyloid beta A4 
protein
App
P16014 ENSMUSG00000027350 Secretogranin-1 Chgb
Q06335 ENSMUSG00000031996 Amyloid-like 
protein 2
Aplp2
P70663 ENSMUSG00000029309 SPARC-like 
protein 1
Sparcl1
P26339 ENSMUSG00000021194 Chromogranin-A Chga
Q0VGU4 ENSMUSG00000037428 Vgf Vgf
P10923 ENSMUSG00000029304 Osteopontin Spp1
P29699 ENSMUSG00000022868 Alpha-2-HS-
glycoprotein
Ahsg
P19788 ENSMUSG00000030218 Matrix Gla protein Mgp
Q9WUU7 ENSMUSG00000016256 Cathepsin Z Ctsz
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Figure 3. Calcifications in Pdgfbret/ret and Slc20a2−/− mice grow in size 
and number with age and are composed of both pro- and anti-osteogenic 
proteins. Representative images of immunohistochemical verification of 
the proteomic analysis in Pdgfbret/ret and Slc20a2−/− using antibodies 
targeting SPARCL1, APP and APLP2 (A). B. Weak (OPN, CHGA, VGF) or 
negative (CTSZ and MGP) immunostaining in Pdgfbret/ret with antibodies 
targeting enriched proteins in calcifications with proteomics. Scale bars, 
50 µm. C. Measurements of the calcification surface area and volume 
(D) in 2- (n = 4), 6- (n = 3) and 12-month-old (n = 3) Pdgfbret/ret mice. A 
one-way ANOVA with Bonferroni correction for multiple comparisons 
demonstrates statistically significant difference between 6 and 12 
months analyzed mice (***P < 0.001).
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Figure 4. Nodules found in Pdgfbret/ret and Slc20a2−/− mice differ in 
anatomical location and morphology. A. Representative images of 
Alizarin red stainings performed on sections from 3-, 6- and 12-month-
old Pdgfbret/ret and Slc20a2−/− demonstrate the increase in both size and 
number of the nodules in both models. Calcifications were absent in 
Pdgfbret/+ and Slc20a2+/− controls. Scale bars, 1000  µm in overview 
pictures and 100 µm in higher magnification. B. Distribution of nodules 
in different brain regions in 3-, 6- and 12- -month-old Pdgfbret/ret (n = 9) 
and Slc20a2−/− (n = 6). The numbers are displayed as the percentage of 
nodules found in each area compared to the total number of nodules 
found for all time points. C. High magnification views from 12-month-old 
Pdgfbret/ret and Slc20a2−/− showing the difference in morphology. Scale 
bars, 100 µm in overview pictures and 50 µm in higher magnification. D. 
Representative images of the close association between astrocytes and 
microglia to calcified nodules detected in a 5-month-old Pdgfbret/ret  
(n = 1) and 6-month-old Slc20a2−/− mice visualized with EM (n = 2).
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Figure 5. Astrocyte and microglia processes encompass most of the 
nodule circumference. A. Representative confocal images of six optical 
stacks showing co-immunolabeling for SPARCL1, GFAP and IBA1. Arrow 
indicates the surface area of the nodule in contact with IBA-positive 
microglia and arrowheads indicate the surface area of the nodule in 
direct contact with GFAP-positive reactive astrocyte processes. Scale 
bar, 10 µm. B. Volumetric 3D rendering of a nodule stained with APP 
(red) associated with a GFAP-positive astrocyte (green) and IBA1-
positive microglia (white). C. Co-immunolabeling with APP, IBA1 and 
GFAP confirming the association of nodules with astrocytes and 
microglia in both Pdgfbret/ret and Slc20a2−/− mice. Scale bars, 50 µm. D, 
E. Percentage of calcifications associated with astrocytes and microglia 
in deeper brain regions in  (D) 2- (n = 4) and  (E) 12-month-old (n = 3) 
Pdgfbret/ret mice.
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we investigated the whole brain dataset from Zeisel et al 
(47) to get a broad overview of gene expression also in 
non-vascular cell types in the brain.
By single-cell RNA sequencing, App and Aplp2 expressions 
were observed in all cell types of the BBB (Figure 8A), 
with the highest expression in neurons (Figure 8B). Similarly, 
Figure 6. Nodules in Pdgfbret/ret and Slc20a2−/− are confirmed to be 
vessel associated. A. Small vessel association of calcifications in 
Pdgfbret/ret and Slc20a2−/− mice verified by co-immunolabeling with APP, 
CD13 and CD31 on vibratome sections. Scale bars, 50 µm. B. Volumetric 
3D rendering of a calcification in Pdgfbret/ret (red) attached to a CD31-
positive vessel (purple). C. Percentage of calcifications associated with 
vessels in deeper brain regions in 2- (n = 4) and 12-month-old (n = 3) 
Pdgfbret/ret mice.
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Sparcl1 was expressed by almost all cells of the brain, with 
the highest expression in astrocytes (Figure 8A,B). Considering 
the close apposition between astrocytes and calcified nodules, 
this may suggest that astrocytes are the main source of the 
SPARCL1 protein deposited into the nodules. Conversely, 
Ctsz is also expressed by almost all cell types, but most 
prominently by microglia, the second cell type apposing the 
calcified nodules (Figure 8A,B), suggesting a microglial origin 
of CTSZ protein in the nodules. As these proteins were 
produced by almost all cell types of the brain, we investigated 
if regional difference in expression might explain the 
occurrence of calcifications predominantly in the deeper brain 
regions of Pdgfbret/ret mice. We extracted microvascular frag-
ments of the cortex and deeper brain regions and compared 
expression levels of App, Aplp2 and Sparcl1. Interestingly, 
the level of Sparcl1 mRNA was higher in the deeper brain 
regions compared to cortex, with a tendency for the highest 
production in Pdgfbret/ret mice (Figure 8C).
Ahsg, Chga, Chgb and Vgf were not produced by the 
BBB cells (Figure 9A), but Chga, Chgb and Vgf were promi-
nently expressed by neurons (Figure 9B), suggesting that 
these proteins may passively adhere to and become integrated 
Figure 7. Assessment of pericyte coverage and blood–brain barrier 
integrity in Slc20a2−/−. A. Representative images from hypothalamus of 
3-month-old Slc20a2+/− and Slc20a2−/− mice. Co-immunolabeling with 
CD31 and CD13 was performed on 50 µm thick sagittal vibratome 
sections. Scale bars, 50 µm. B, C. The capillary surface coverage ratio in 
3- and 12-month-old Slc20a2+/− mice compared to Slc20a2−/− (n = 4). 
Two-tailed Student’s t-test demonstrates no statistically significant 
difference between the different genotypes or different regions within 
the same genotype. D. 1 kDa Alexa Flour 555 conjugated cadaverine (25 
µg/g body weight) was injected into the tail vein to assess for blood–
brain barrier integrity. The relative fluorescence unit per gram of tissue 
(RFU/Tissue [g]) was measured in brain homogenate of 3-month-old 
Slc20a2+/−, Pdgfbret/ret and Slc20a2−/− (n = 3). A one-way ANOVA with 
Bonferroni correction for multiple comparisons indicates statistical 
significance (***P  <  0.001).
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Figure 8. App, Aplp2, Sparcl1 and Ctsz are common components of the 
brain extracellular matrix. Broad expression of App, Aplp2, Sparcl1 and 
Ctsz can be detected in different cells of (A) the blood–brain barrier 
(http://betsh oltzl ab.org/Vascu larSi ngleC ells/datab ase.html) and (B) the 
whole brain (http://linna rsson lab.org/corte x/). Every spike represents the 
expression level in an individual cell. C. qPCR for the expression of App, 
Aplp2 and Sparcl1 in microvascular fragments of calcification prone and 
non-calcification prone regions of Pdgfbret/+ and Pdgfbret/ret mice. A two-
tailed Student’s t-test indicates significant differences (*P < 0.05, ***P 
< 0.001).
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Figure 9. Ahsg, Chga, Chgb and Vgf are not expressed by blood–brain 
barrier cells. A. Single cell expression of Ahsg, Chga, Chgb and Vgf in 
the cells of the blood–brain barrier. Except for an occasional expression 
of Chga in astrocytes, no expression of the four aforementioned genes 
could be detected. B. In the whole-brain single-cell dataset, expression 
of Chga, Chgb and Vgf was mostly restricted to the neurons. Expression 
of Ahsg could not be detected.
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with the growing nodules, rather than being actively depos-
ited by the nodule-associated cells. Ahsg could not be detected 
in the whole brain dataset, most likely due to rare expres-
sion of the gene or insufficient detection sensitivity of the 
single-cell technology used. Alternatively, it is produced in 
the periphery and gets incorporated into the nodules fol-
lowing BBB passage.
Interestingly, both Spp1 and Mgp have a very specific 
expression profile in the brain vasculature. A subset of 
pericytes and fibroblast-like cells express Spp1, (Figure 10A), 
whereas no other cell types express Spp1 in the brain (Figure 
10B). Expression of Mgp is slightly broader, with the strong-
est expression in the fibroblast-like cells and minor but 
detectable expression in the largest arterial endothelial cells 
and mural cells (Figure 10A). In addition, we could observe 
an inverse correlation between expression of Spp1 and Mgp 
in perivascular fibroblast-like cells (Figure 10C), suggesting 
alternating pro and anti-calcification processes in these cells. 
Finally, we were able to match the expression profiles of 
Sparcl1, Mgp and Ctsz with the corresponding cellular 
expression in the tissue using antibodies (Figure 10D). 
SPARCL1 was confirmed to be highly expressed by GFAP-
positive astrocytes while MGP co-localized with PDGFRA-
positive perivascular fibroblasts and CTSZ with IBA1-positive 
microglia.
Taken together, these data suggest that several different 
cell types contribute protein components to the calcified 
nodules in mouse PFBC models. It is important to remem-
ber, however, that the mRNA expression profiles analyzed 
above were derived from normal healthy adult mice and 
that expression profiles in Scl20a2−/− and Pdgfbret/ret mice 
might differ from the normal.
Astrocytes are the common expression site for 
cell autonomously acting PFBC genes
The similarity in nodular protein composition and the fact 
that activated astrocytes and microglia adhere to the calci-
fied nodules in both Slc20a2−/− and Pdgfbret/ret mice suggest 
common pathogenic mechanism, likely involving a perturba-
tion of a common cell type. Since Slc20a2−/− mice displayed 
normal pericyte abundance and microvascular morphology, 
as well as a generally intact BBB, we looked for a common 
site of expression of known PFBC genes among all vascular 
and vessel-associated cell types. Utilizing our recently pub-
lished single-cell RNA sequencing resource (38), we found 
that the only cell type expressing all four PFBC genes with 
assumed cell-autonomous action (Slc20a2, Xpr1, Pdgfrb and 
Myorg) was astrocytes (Figure 11). The common expression 
in astrocytes therefore suggests a critical involvement of 
this cell type in PFBC pathogenesis.
DISCUSSION
An intriguing feature of PFBC is that calcium phosphate 
deposition occurs around microvessels, hence distinguishing 
the pathogenesis of PFBC from that of atherosclerosis, which 
leads to calcification primarily of large arteries (27, 28). 
Another important feature of PFBC is the specific miner-
alization of brain microvessels, and the preference for deep 
brain regions. Mutations in SLC20A2 (42), PDGFB (17), 
PDGFRβ (29), XPR1 (20) and MYORG (45) are thought 
to be causative for most PFBC cases with a clear family 
history, and therefore we reasoned that genetic animal models 
might provide insight into the pathogenesis.  In the present 
investigation, we utilized two such models, both previously 
shown to recapitulate human PFBC with regard to the 
formation of vascular calcification in the deep brain regions 
(14, 17). Pdgfbret/ret and Slc20a2−/− mice develop brain cal-
cifications that expand in both size and number with age. 
We made an in-depth comparison between the two models 
and unveiled new insights into the ultrastructure, protein 
composition and cell type association of the calcified nod-
ules, thereby providing novel insights into the pathophysiology 
of PFBC.
Previously reported anatomical locations of  the calcifica-
tions and their age-dependent growth in size and number 
(14, 15, 17) were largely confirmed in our present study. 
However, unlike a previous study (40), we did not detect 
any calcifications in Slc20a2-/+ heterozygous mice. These 
might indeed be very rare events (15), and the detection 
of  calcified lesions in Slc20a2-/+ mice by Wallingford et 
al is likely due to different levels of  backcrossing of  the 
mouse strain.
Intriguingly, we found differences between Pdgfbret/ret and 
Slc20a2−/− mice concerning lesion ultrastructure and loca-
tion. While Pdgfbret/ret nodules were spherical and smooth 
surfaced to the most extent (although they occasionally also 
display rugged surfaces, as pointed out above), grow indi-
vidually and were concentrated to the thalamus, pons and 
midbrain even at advanced age, the nodules in Slc20a2−/− 
mice were mulberry shaped and present throughout the 
brain, albeit with a preference for the deeper brain regions. 
As Pdgfb is also expressed in brain regions that do not 
present calcifications (e.g. cortex) (47) (http://linna rsson lab.
org/corte x/), the observed difference in anatomical location 
is most likely not due to focused expression of Pdgfb in 
different brain regions. Local differences in susceptibly to 
mineral deposition may explain the disparity in distribution 
of calcifications between the two models.
Using LC-MS/MS, we identified several proteins to be 
highly enriched in the calcifications of Pdgfbret/ret mice. 
Astonishingly, the most abundant proteins in the nodules 
are known to play roles in bone formation and ectopic 
tissue mineralization, including both proteins that have been 
proposed to promote (SPARCL1) and inhibit (OPN, MGP 
and AHSG) tissue mineralization. The involvement of both 
types of proteins is perhaps not entirely unexpected, since 
both functions are required for bone remodeling. This remod-
eling process bears resemblance with inflammation/tissue 
repair in the sense that a balance of opposing mechanisms 
is observed (32). For example, SPARCL1 is expressed in 
bone structures (8), whereas OPN, MGP protein and AHSG 
are recruited as inhibitors of mineralization (24, 33). Also, 
the occurrence of SPARCL1 in the nodules is noteworthy, 
since SPARCL1 is an ancestral mineralization protein. 
However, SPARCL1 is abundantly expressed in the brain 
Nahar et alPFBC Pathology in Two Mouse Models
Brain Pathology 0 (2019) 1–19
© 2019 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology
14
Figure 10. Spp1 and Mgp are selectively expressed in specific cell 
types of the blood–brain barrier. A. Spp1 is only expressed in a 
subpopulation of pericytes, as well as the fibroblast-like cells. Mgp 
displays low expression in all mural cells and the largest arterial 
endothelial cells, but high expression in the fibroblast-like cells. B. No 
selective Spp1 expression can be detected in the whole-brain dataset, 
but Mgp is highest in the mural cell group and a subset of endothelial 
cells. C. Detailed close-up of the two fibroblast-like cell types indicate an 
inverse correlation between expression of Spp1 and Mgp. Green dotted 
lines are a visual aid to appreciate the location of the cells on the X-axis. 
Note that the postion of all cells in the single-cell database are fixed on 
the X-axis, allowing comparison of gene expression on a cell-to-cell 
basis. D. Confocal images confirming the expression of SPARCL1 in 
GFAP-positive astrocytes, MGP in PDGFRA-positive perivascular 
fibroblast and CTSZ in IBA1-positive microglia in 12-month-old Pdgfbret/+ 
animal. Staining for ASMA was used to pinpoint the perivascular 
localization of the PDGFRA-positive cells to arteries. HOECHST was 
used to visualize the individual nuclei of the cells. Scale bars, 10 µm.
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(34) and in particular by astrocytes (5) and its accumulation 
may reflect a natural reaction, or protection, against an 
ectopic process or structure. A similar reaction may explain 
the enrichment of APP and APLP2 in the calcifications. 
APP and APLP2 are members of the APP family of pro-
teins, where APP is central in Alzheimer’s disease where it 
is the precursor protein for the amyloid beta peptides. Some 
studies suggest that the role of native APP and its gene 
family members are crucial for the formation, maintenance 
and plasticity of synapses in the CNS (23, 44).
The Pdgfb and Pdgfrb encoded proteins PDGF-B and 
PDGF-Rβ have previously been show to play critical roles 
in pericyte recruitment to the brain microvasculature (1, 12, 
21). Pericytes, in turn, have been demonstrated to play impor-
tant roles in the development and maintenance of the BBB 
(4). By studying different Pdgfb mouse mutants with different 
degrees of pericyte loss and BBB disruption, we also found 
a good correlation with the severity of the PFBC phenotype 
(17). However, subsequent studies of different brain regions 
in Pdgfbret/ret showed an opposite correlation: the minerali-
zation-prone deep brain regions had higher pericyte densities 
and less BBB disruption compared with the cerebral cortex, 
which lacked mineralized lesions (39). Our present analysis 
of Slc20a2−/− mice confirms that these mice do not present 
pericyte loss and they do not have increased general perme-
ability of low-molecular weight tracers. In spite of these 
differences, the two mouse models do share fundamental 
similarities. The nodules display a multilayer structure and 
the presence of certain specifically enriched proteins in the 
nodules were found in both Pdgfbret/ret and Slc20a2−/−. 
Moreover, the close interaction with astrocytes, microglia and 
vasculature to calcifications was consistently observed. 
Astrocyte–microglial reactivity around calcifications also 
occurs in PFBC patients (28), and the relation between the 
nodules and astrocytes has been described in mice (15, 46). 
Concomitantly, we demonstrate here that microglial reactivity 
also occurs in both mouse models, strengthening their role 
as a model for PFBC. Although we currently have no evi-
dence that these cells are causative for the calcification forming 
process, we hypothesize that these cells may be involved in 
the deposition and breakdown of the calcified nodules similar 
to how osteoblasts and osteoclasts balance the turnover of 
bone matrix. In addition, Zarb et al recently showed that 
the astrocytes in apposition to the calcification are reactive 
(46). The observation that astrocytes is the only cell type 
that expresses all four cell-autonomously acting genes, Slc20a2, 
Pdgfrb, Xpr1 and Myorg, points to a central role for these 
cells in the capillary calcification that occurs in PFBC.
MATERIAL AND METHODS
Ethics statement
The present study was conducted in agreement with the 
recommendations from the Swedish Ethical Committee on 
Animal Research and was approved by the Uppsala Ethical 
Committee on Animal Research (permit number: C224/12 
and C115/15). All efforts were made to minimize suffering 
of the animals and both males and females were used in 
this study.
Transgenic mice
The generation of Pdgfbret/ret mice has been described previ-
ously (22). Transgenic Slc20a2tm1a-(EUCOMM)Wtsi) were obtained 
from the European Mouse Mutant Archive (EMMA, 
Germany). For all experiments, full knockouts mice of either 
sex were analyzed at appropriate time points and heterozy-
gote littermates were used as controls.
Figure 11. Astrocytes are the common expression site for cell autonomously acting PFBC genes. Single-cell expression of Slc20a2, Myorg (also 
called AI464313), Xpr1 and Pdgfrb. Note that Pdgfrb is also expressed in astrocytes, yet to a lower level as compared to its expression in pericytes.
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Histology
For histological stainings, anesthetized mice were perfused with 
HBSS, fixed with 4% paraformaldehyde and then postfixed 
at 4°C in 4% paraformaldehyde for 4  h. Sagitally devided 
brain halves were embedded in paraffin and all histological 
alizarin red stainings were performed on 10 µm thick sections 
at the Clinical Pathology at Academic Hospital, Uppsala in 
accordance with previously described procedures (17).
Electron microscopy
For electron microscopy (EM), 5- (n = 1, male) and 9-month-
old (n = 1, male) Pdgfbret/ret and 6-month-old (n = 2, male 
and female) Slc20a2−/− mice were perfused with Hanks’ 
Balanced Salt solution (HBSS, Sigma Aldrich) and then 
fixed with 3% formaldehyde and 0.5% glutaraldehyde in 
0.1  M sodium cacodylate buffer (pH 7.2). The brains were 
postfixed in 3% paraformaldehyde and 2.5% glutaraldehyde 
in 0.1 M sodium cacodylate buffer (pH 7.2) for 3  h in 4°C 
and stored in 0.15  M cacodylate buffer (pH 7.2). The sam-
ples were cut into 1 mm parasagittal slices and subsequently 
1–2  mm2 large cubic fragments from areas of interest under 
the stereomicroscope prior to examination with EM. After 
osmication and en bloc uranyl acetate treatment, tissue blocks 
were dehydrated and embedded in epoxy resin. Sections 
were cut with a diamond knife on a Leica EM UC7 ultra-
microtome (Leica Microsystems) at 60  nm thickness setting 
and were examined without additional contrasting in a LEO 
912AB energy-filtered TEM (Carl Zeiss SMT AG). Digital 
images were captured with a MegaView III camera (Olympus 
SiS).
Protein sample preparation and mass 
spectrometry
Calcified nodules from Pdgfbret/ret mice were isolated using 
two different methods. First, laser capture microdissection 
(LCM) was used to isolate sections of nodules from brain 
cryosections (n = 3). Non-calcified neighboring stromal tis-
sue was used as control. Note that we also attempted to 
isolate microvasculature samples in these experiments, but 
were unable to obtain sufficient amount of material for  this 
study. Second, nodules were isolated by manual microdis-
section under a stereomicroscope (n = 1). Aided by the 
inherent autofluorescence of nodules, the tissue was excited 
at 488  nm and visualized in the green spectrum. After iso-
lation, samples were transferred into 10% acetic acid and 
incubated over night at +4°C for complete demineralization 
(modified from previously described method (25). Solubilized 
proteins were precipitated by 4 volumes of acetone at −20°C 
for 1 h, pelleted at 14  000  ×  g for 10  minutes, dried and 
dissolved in urea buffer (6  M urea, 2  M thiourea, 10  mM 
HEPES, pH 8.0). Enzymatic fragmentation of proteins was 
performed by in-solution digestion (3). In brief, protein 
disulfide bonds were reduced with 10 mM dithiothreitol 
and alkylated with 55  mM iodoacetamide. Next, proteins 
were cleaved enzymatically by Lys-C (protein-to-enzyme ratio 
100:1) (Wako Chemicals GmbH, Neuss, Germany) at room 
temperature for 3  h followed by trypsin treatment (protein-
to-enzyme ratio 100:1) (Promega Corporation, Madison, WI) 
at room temperature overnight. Resulting mixture of peptides 
were desalted and concentrated by stop and go extraction 
(STAGE) tips (31). LC-MS/MS and data analysis was per-
formed as already described (37). Briefly, peptides were 
separated by reverse-phase chromatography using an UHPLC 
(EASY-nLC 1000, ThermoFisher Scientific) coupled in line 
to a QExactive Plus orbitrap mass spectrometer (Thermo 
Fisher Scientific) using an electrospray ionization source. 
Peptides separation occurred by pre-column (100  µm ID, 
5  µm C18-beads) and analytical columns (75  µm ID, 3  µm 
C18-beads) (Thermo Fisher Scientific) using a linear gradi-
ent from 4% to 48% acetonitril with 0.1% formic acid for 
138 minutes at a flow rate of 250  nL/min, followed by 75% 
acetonitril for 6  minutes and 4% acetonitril for 6  minutes 
for re-equilibration. Positive ion MS spectra (m/z = 400–1750) 
were acquired using an automatic gain control (AGC) target 
of 3E6 at a resolution of 70  000. The ten most intense 
peaks were isolated for higher energy collisional dissociation 
(HCD) fragmentation (25% normalized collision energy) and 
MS/MS spectra were generated with an AGC target of 5E5 
at a resolution of 17  500. Mass spectrometer worked in 
data-dependent mode.
MS raw data were processed by MaxQuant (1.5.0.25) (9) 
using the Uniprot human database (release 2014-07). The 
following parameters were used for data processing: Maximum 
of two miss cleavages, mass tolerance of 4.5  ppm for main 
search, trypsin as digesting enzyme, carbamidomethylation 
of cysteins as fixed modification, oxidation of methionine 
and acetylation of the protein N-terminus as variable modi-
fications. Peptides with a minimum of seven amino acids 
and at least one unique peptide were required for protein 
identification. Only proteins with at least two peptides and 
at least one unique peptide were considered as identified 
and used for further data analysis.
Immunohistochemistry on vibratome sections
For immunohistochemical (IHC) analyses, anesthetized mice 
were perfused with HBSS, fixed with 4% paraformaldehyde 
and then postfixed at 4°C in 4% paraformaldehyde for 4  h. 
Fifty micrometers brain sagittal vibratome sections were 
incubated at 4°C in blocking/permeabilizing solution (1% 
bovine serum albumin, 0.5% TritonX-100 in PBS) for 24 
h. Primary antibodies diluted in 0.25% TritonX-100 PBS 
were incubated for 48 h at 4°C. The sections were washed 
in 0.25% TritonX-100 PBS and incubated in secondary 
antibodies diluted in 0.25% TritonX-100 PBS for 24  h at 
4°C. After washing with 0.25% TritonX-100 PBS and PBS, 
samples were mounted in Prolong Gold antifade reagent 
(Life Technologies). Primary antibodies used for immu-
nostainings can be found in Supplementary Table S4. All 
sections were analyzed using a Leica TCS SP8 Confocal 
Microscope (Leica Microsystems). Images were processed 
by Fiji (ImageJ2) and Adobe Illustrator CS6 and 2D maxi-
mum intensity projections of ~30–50 μm z-stacks were ana-
lyzed for quantification.
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Tracer experiments
For BBB integrity analysis, 1  kDa Alexa Flour-555 conju-
gated cadaverine (25  µg/g body weight) was injected into 
the tail vein 2  h prior to sacrificing the mice as previously 
described  (4). Briefly, the animals were anesthetized, tran-
scardially perfused for 4  minutes with HBSS and brain and 
kidney were collected. Half  of the cerebrum and one kidney 
were homogenized in 1% Triton X-100/PBS (pH 7.2) and 
the lysates were centrifuged at 14  000 rpm at 4°C for 
20  minutes. The relative fluorescence of the supernatant 
was measured using a Synergy HT microplate reader (BioTek) 
with the following settings: 540/25  nm for excitation and 
590/20  nm for emission. Kidneys were used as controls to 
ensure the systematic distribution of the injected tracer. 
Results were expressed as relative fluorescent units normal-
ized to tissue weight (RFU/g).
Measurement of nodule size and association 
with vessel and astrocytes/microglia
For calcification measurements (surface area and volume) 
and analysis of  nodule association with vessel or astro-
cytes/microglia, pictures from midbrain and thalamus were 
acquired from 8–14 fields per animal. All nodules were 
measured and analyzed for cellular and vessel association 
in cases were several nodules were observed within the 
same field. Volumetric rendering and measurement of  cal-
cifications was done with Volocity v.6.31 (PerkinElmer) 
and Imaris ×64 8.3.1 (Bitplane, Belfast, UK). The total 
number of  analysed nodules in Pdgfbret/ret mice (n ≥ 3 
per age) were as follows: 2-month old (n = 76), 6-month 
old (n = 71) and 12-month old (n = 89).
Quantification of pericyte coverage
Pericyte coverage was calculated with the AnalyzeSkeleton 
plugin in Fiji (https ://fiji.sc/). Three-dimensional confocal 
image stacks were projected with maximum intensity projec-
tion, contrast enhanced, de-speckled, smoothened and a 
threshold was set for generating a binary image. These images 
were then subjected to “dilate” and “close” commands prior 
to running the AnalyzeSkeleton plugin. Total skeletal length 
was calculated for both anti-CD31 stained images (all ves-
sels) and anti-CD13 stained images (pericyte covered vessels), 
and the ratio of vessel length was used as a measurement 
of coverage. All image processing was done automatically 
with a custom macro designed in Fiji.
Real-time quantitative PCR (RT-qPCR)
Brain vasculature was isolated with Dynabeads (Dynabeads® 
Sheep Anti-Rat IgG, Thermofisher Scientific, cat# 11035) 
coupled to rat anti-mouse CD31 (BD Pharmingen, cat# 
553370). Total RNA was extracted from microvascular 
fragments from different mouse brains regions and DNase-
treated using the RNeasy Lipid Tissue Mini kit (Qiagen). 
cDNA was synthetized using the iScriptTM cDNA Synthesis 
Kit (Bio-Rad). Real-time quantitative PCR was performed 
on a CFX96 Touch RT-PCR machine (Bio-Rad) using 
TaqMan probes (Life Technologies). In all conditions, 
eukaryotic 18S rRNA (4319413E) was used as a reference 
gene for ΔΔCt calculations. The following TaqMan probes 
were used: Mouse Pdgfrb (Mm00435546_m1), mouse 
Sparcl1 (Mm00447784_m1), mouse App (qMmu-
CIP0033061) and mouse Aplp2 (qMmuCEP0041974). All 
RT-PCR data are represented as the mean of  three inde-
pendent experiments.
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SUPPORTING INFORMATION
Additional supporting information may be found in the online 
version of this article at the publisher’s web site:
Table S1. Proteomic analysis of the calcified nodules. The first 
tab presents an overview of the detected proteins in each exper-
imental setup, with the number of unique peptide matches for 
each detected protein. The second tab provides an overview 
of the detected proteins for each experimental sample. Calzi: 
Calcified nodule extracted via microdissection. Brain: Control 
brain parenchyma obtained via microdissection. The laser 
capture microdissection samples are coded with a number, fol-
lowed by a letter and finally, a dash with a number. The first 
number represents the mouse used (biological replicate, n = 3). 
A = calcified nodule, B = control, C = microvascular fragment. 
-1: extraction without demineralization. -2: extraction with 
demineralization.
Table S2. Proteins detected exclusively in the calcifications 
after stereomicroscope microdissection.
Table S3. Proteins detected exclusively in the calcifications 
after laser capture microdissection.
Table S4. List of antibodies used for immunofluorescence 
stainings.
Movie S1. Dynamic interaction of calcifications with GFAP-
positive reactive astrocyte and IBA1-positive microglia. 
Animation of confocal z-stacks showing the dynamic interac-
tion of GFAP-positive astrocyte and IBA1-positive microg-
lia to a lesion (labeled with anti-SPARCL1 antibody) found 
in a 3-month-old Pdgfbret/ret mouse. SPARCL1, GFAP and 
IBA1 channels were combined and the animation was gen-
erated with LAS AF software (Leica Microsystems) and Fiji 
(https ://fiji.sc/).
Movie S2. Association of a nodule with astrocyte and 
microglia. Animation of volumetric 3D rendering of con-
focal z-stacks illustrating a nodule tightly associated with 
astrocyte and microglia in a 3-month-old Pdgfbret/ret mouse. 
Co-immunostaining of APP, GFAP and IBA1 was performed 
on 50 µm thick parasagittal vibratome sections and 2D pro-
jections of the three merged channels were acquired prior to 
subjection to 3D-rendering. Calcification is seen in red, GFAP-
positive cells in green and IBA1-positive cells in cyan.
Movie S3. Association of a nodule to small vessels. Animation 
of volumetric 3D rendering of confocal z-stacks computed 
in Volocity v.6.31 (PerkinElmer) depicting a nodule tightly 
associated with a capillary in a 3-month-old Pdgfbret/ret. 
Co-immunostaining of APP, CD31 and CD13 was performed 
on 50 µm thick parasagittal vibratome sections and 2D pro-
jections of the three merged channels were acquired prior to 
subjection to 3D rendering. Calcification is seen in red and 
vessels in purple.
